Clinical Trials for Novel Neuromodulation Therapies
NIH UH3 NS119844, “Defining Targets for Tic Detection and Suppression in Tourette Syndrome Deep Brain Stimulation”
Project Period: 9/17/2021 – 9/16/2026
https://clinicaltrials.gov/ct2/show/NCT05371041
https://reporter.nih.gov/search/F9dND3SAOUaspT-25XzjAA/project-details/10290544
NIH UH3 NS109557, “Thalamocortical responsive neurostimulation for the treatment of Lennox-Gastaut Syndrome”
Project Period: 06/01/2021 – 05/31/2026
https://clinicaltrials.gov/ct2/show/NCT05339126
https://reporter.nih.gov/search/9QOSlQTwPkyYvO7r74lnrA/project-details/9958791
NIH UG3/UH3 NS112826, “Thalamic stimulation to prevent impaired consciousness in epilepsy”
Project Period: 9/1/19 – 8/31/24
https://clinicaltrials.gov/ct2/show/NCT04897776
https://reporter.nih.gov/search/SZcSUYlbI0-P0UWJO8uoig/project-details/10017335
NIH R01 NS111019, “Central thalamic deep brain stimulation to regulate arousal and cognition”
Project Period: 4/1/20 – 3/31/24
https://reporter.nih.gov/search/_cMQOq8MSEufRQYnBh_S0A/project-details/10246247
NIH UH3 NS095554, “Central thalamic stimulation for traumatic brain injury”
Project Period: 9/20/15 – 8/31/22
https://clinicaltrials.gov/ct2/show/NCT02881151
https://reporter.nih.gov/search/xUU7Szt87EeXE_IpxgBldQ/project-details/10246247